2017
DOI: 10.1016/s2352-4642(17)30066-4
|View full text |Cite
|
Sign up to set email alerts
|

Pulse oximetry screening for critical congenital heart defects: a European consensus statement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0
6

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 41 publications
(23 citation statements)
references
References 11 publications
0
17
0
6
Order By: Relevance
“…However, in cases of suspicion of a non-critical defect or for patients with low pre-test probability a more expectative management can be provided. Moreover, the use of pulse-oximetry screening for congenital heart defects is useful and should be integrated into the clinical decision-making process, as internationally recommended [168,169].…”
Section: Discussionmentioning
confidence: 99%
“…However, in cases of suspicion of a non-critical defect or for patients with low pre-test probability a more expectative management can be provided. Moreover, the use of pulse-oximetry screening for congenital heart defects is useful and should be integrated into the clinical decision-making process, as internationally recommended [168,169].…”
Section: Discussionmentioning
confidence: 99%
“…Pulse oximetry (PO) screening to detect critical congenital heart defects (CCHD) in newborns has been studied widely in the past years and was proven to be accurate, safe, easy, and acceptable in settings with delivery and screening in hospital [6, 12, 15, 23, 30]. Cost-effectiveness analyses performed in studies from the USA and UK also suggest that the screening might be cost-effective in their setting [21, 25].…”
Section: Introductionmentioning
confidence: 99%
“…They concluded that there is a need for a European Consensus on CCDH screening in Europe [18]. Recently, a panel from The European Pulse Oximetry Screening Workgroup investigating pulse oximetry screening for critical congenital heart defects published a European consensus statement that recommended the use of pulse oximetry for the early detection of CCDH in all European countries, using new-generation equipment that is motion tolerant; screening after 6 h of delivery and before discharge from the birth center, preferably within the 24 h after birth; and using two extremities, the right hand and either foot [19]. In addition, guidelines for the management of CCDH have been implemented, including practical aspects and nomograms to facilitate the management of these babies [20].…”
Section: Discussionmentioning
confidence: 99%